Medical device and methods of delivering the medical device

Information

  • Patent Grant
  • 9168120
  • Patent Number
    9,168,120
  • Date Filed
    Friday, September 7, 2012
    12 years ago
  • Date Issued
    Tuesday, October 27, 2015
    9 years ago
  • CPC
  • Field of Search
    • US
    • 600 037000
    • 600 029000
    • 600 030000
    • 606 041000
    • CPC
    • A61B2017/00805
    • A61B17/0401
    • A61F2/0045
  • International Classifications
    • A61F2/00
    • A61F13/00
    • Term Extension
      272
Abstract
The present invention discloses a medical device and a method of placing the medical device within a patient's body. The medical device includes a support member, a first elongate member, a second elongate member and a coupling member. The first elongate member and the second elongate member extend from the support member. The coupling member includes a first portion and a second portion. The first portion of the coupling member is coupled to a distal end portion of the first elongate member and the second portion of the coupling member is coupled to a distal end portion of the second elongate member.
Description
BACKGROUND

1. Field


The present invention generally relates to implants and more particularly to bodily implants and their methods of delivery and placement into a patient's body for the treatment of pelvic floor repair.


2. Description of the Related Art


Genital prolapse or pelvic floor prolapse is the protrusion of pelvic organs into or out of the vaginal canal. Pelvic floor prolapse affects many women and many of them undergo at least one reconstructive pelvic surgery in their lifetime. Many of the cases may be the result of damage to the vaginal and pelvic support tissue by stretching or tearing of the connective tissue within the pelvic space due to childbirth, age, obesity, post-menopausal conditions or chronically elevated intra-abdominal pressure. The results are the distention of organs such as the bladder and rectum, into the vagina, as well as various stages of vaginal avulsion.


Surgical therapy may be performed for the treatment of pelvic organ prolapse. Such surgeries for prolapse treatment may include plication of the torn connective tissues and re-suspension of the vagina. Some traditional suspension techniques include utero-sacral suspension and sacrospinus ligament suspension. Some procedures for vaginal suspension include sacrocolpopexy, where the vagina is suspended to the sacral promontory with an implanted graft material.


Hysterectomy may be performed before conducting sacrocolpopexy. It involves surgical removal of the uterus so that the bodily implant can be attached properly to the anterior and posterior vaginal walls. Hysterectomy may be total (removal of the cervix and the uterus) or partial (removal of the uterus while leaving the cervix intact). This may be an undesirable outcome of pelvic floor repair as removal of the uterus can create many complications and render the patient unable to bear children. Therefore, many women do not prefer removal of the uterus.


Therefore, a medical device and a method for placing the medical device within the patient's body is required that overcomes the need of removal of the uterus through either total or partial hysterectomy.


SUMMARY

The present invention discloses a medical device and a method of placing the medical device within a patient's body. The medical device includes a support member, a first elongate member, a second elongate member and a coupling member. The first elongate member and the second elongate member extend from the support member. The first elongate member and the second elongate member include a proximal end portion and a distal end portion. The proximal end portion of the first elongate member is configured to be attached to the support member and the distal end portion of the first elongate member is configured to be attached around a portion of a uterus. The proximal end portion of the second elongate member is configured to be attached to the support member and the distal end portion of the second elongate member is configured to be attached around a portion of a uterus. The coupling member includes a first portion and a second portion. The first portion of the coupling member is coupled to the distal end portion of the first elongate member and the second portion of the coupling member is coupled to the distal end portion of the second elongate member. The first portion of the coupling member and the second portion of the coupling member are further configured to be coupled together.





BRIEF DESCRIPTION OF THE FIGURES

The invention and the following detailed description of certain embodiments thereof may be understood with reference to the following figures:



FIG. 1 is a schematic diagram of a medical device configured to be placed within a patient's body, in accordance with an embodiment of the present invention.



FIG. 2 is a perspective illustration of a medical device configured to be placed within a patient's body, in accordance with an embodiment of the present invention.



FIG. 3A is an enlarged view of a coupling member in a decoupled state, in accordance with an embodiment of the present invention.



FIG. 3B is an enlarged view of the coupling member of FIG. 4A in a coupled state, in accordance with an embodiment of the present invention.



FIG. 4A illustrates placement of a medical device within a patient's body in a top view of a vaginal opening, in accordance with an embodiment of the present invention.



FIG. 4B illustrates placement of the medical device of FIG. 5A within a patient's body in a bottom view of a vaginal opening, in accordance with an embodiment of the present invention.



FIG. 4C illustrates placement of the medical device of FIG. 5A within a patient's body, with the coupling member in a coupled state, in accordance with an embodiment of the present invention.



FIG. 5 is a flowchart illustrating a method of placing a medical device within a patient's body, in accordance with an embodiment of the present invention.





DETAILED DESCRIPTION

Detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention in virtually any appropriately detailed structure. Further, the terms and phrases used herein are not intended to be limiting, but to provide an understandable description of the invention.


The terms “a” or “an,” as used herein, are defined as one or more than one. The term “another,” as used herein, is defined as at least a second or more. The terms “including” and/or “having”, as used herein, are defined as comprising (i.e., open transition). The term “coupled” or “operatively coupled,” as used herein, is defined as connected, although not necessarily directly and mechanically.


In general, the invention is directed to systems, methods, and devices for treating uterine prolapse. However, the invention may be equally employed for other treatment purposes such as pelvic organ prolapse. As described below in various illustrative embodiments, the invention provides systems, methods, and devices employing an improved medical device configured to be implanted within a patient's body to support pelvic organs for the treatment of pelvic prolapse.


The term patient may be used hereafter for a person who benefits from the medical device or the methods disclosed in the present invention. For example, the patient may be a person whose body receives the medical device disclosed by the present invention in a surgical treatment. For example, in some embodiments, the patient may be a human female, or any other mammal.



FIG. 1 is a schematic diagram of a medical device 100 configured to be implanted within a patient's body, in accordance with an embodiment of the present invention. The medical device 100 includes a support member 102, a first elongate member 104, a second elongate member 106 and a coupling member 108. The first elongate member 104 includes a proximal end portion 110 and a distal end portion 112. Similarly, the second elongate member 106 includes a proximal end portion 114 and a distal end portion 116. The coupling member 108 includes a first portion 118 and second portion 120.


The support member 102 is configured to be placed within a patient's body such that the support member 102 disposed adjacent a first bodily portion. In some embodiments, the support member 102 is attached or stitched to the first bodily portion. In some embodiments, the first bodily portion is a portion of an anterior vaginal wall of the patient such that the support member 102 is attached or stitched to the portion of the anterior vaginal wall. In other embodiments, the first bodily portion is a portion of a posterior vaginal wall of the patient such that the support member 102 is configured to support the portion of the posterior vaginal wall.


The support member 102 can be of different shapes, sizes, and configurations depending on the indented use of the medical device 100 and location of its placement within the body of the patient. In some embodiments, the support member 102 can be substantially rectangular, square, oval, or elliptical. The support member 102 can be shaped and sized in conformation to the portions of the vaginal walls of the patient where it is attached or stitched. In accordance with several embodiments, the support member 102 may be configured to conform to the shape of the body of the patient. For example, the support member 102 may be placed in a crescent shape, such as in the shape of a crescent moon, to help it conform to the shape of the anterior wall of the vagina.


The first elongate member 104 extends from the support member 102. The proximal end portion 110 of the first elongate member 104 is attached to the support member 102 and the distal end portion 112 of the first elongate member 104 is configured to be attached around a second bodily portion. In some embodiments, the second bodily portion is a portion of a uterus of the patient such that the distal end portion 112 of the first elongate member 104 is wrapped around the portion of the uterus. In other embodiments, the second bodily portion is a portion of a cervix of the patient such that the distal end portion 112 of the first elongate member 104 is wrapped around the portion of the cervix of the patient. In accordance with some embodiments, the wrapped first elongate member 204 can be stitched around the portion of the uterus or the cervix. Thus the stitched first elongate member 204 provides a support to the uterus and/or the cervix.


The second elongate member 106 extends from the support member 102. The proximal end portion 114 of the second elongate member 106 is attached to the support member 102 and the distal end portion 116 of the second elongate member 106 is configured to be attached around a third bodily portion. In some embodiments, the third bodily portion is a portion of a uterus of the patient such that the distal end portion 116 of the second elongate member 106 is wrapped around the portion of the uterus. In other embodiments, the third bodily portion is a portion of a cervix of the patient such that the distal end portion 116 of the second elongate member 106 is wrapped around the portion of the cervix. In accordance with some embodiments, the wrapped second elongate member 204 can be stitched around the portion of the uterus or the cervix. Thus the stitched second elongate member 204 provides a support to the uterus and/or the cervix. In some embodiments, the second bodily portion and the third bodily portion are same. In some other embodiments, the second bodily portion and the third bodily portion are different.


The first elongate member 104 and second elongate member 106 can be of a variety of different shapes, sizes, and configurations depending on the indented use of the medical device 100 and location of its placement within the body of the patient. In some embodiments, the first elongate member 104 and the second elongate member 106 can be substantially planar, cylindrical, tubular, vasiform, cannular and the like.


In some embodiments, the first elongate member 104 and the second elongate member 106 are integral portions of the support member 102 such that the support member, the first elongate member 104, and the second elongate member form a single integral structure. In other embodiments, the first elongate member 104 and the second elongate member 106 are removably or fixedly coupled to the support member 102 by an operator. The first elongate member 104 and the second elongate member 106 may extend from any location of the support member 102 such that the medical device 100 comfortably supports and retains the prolapsed organ of the patient. In some cases, the first elongated member 104 and the second elongated member 106 can be coupled to the support member 102 at two symmetric locations on either side of a central axis of the support member 102. In other cases, the first elongate member 104 and the second elongate member 106 can be coupled to the support member 102 at two diametrically opposite locations.


In an embodiment, the support member 102, the first elongate member 104, and the second elongate member 106 includes a mesh body that can be made from a biological material or a cadaveric tissue such as stem cells, natural xenograft material, collagen growth factors, and the like. In another embodiment, the support member 102, the first elongate member 104 and the second elongate member 106 includes a mesh body that may be made up of synthetic material such as a plastic, polypropylene mesh or other plastic materials. In some embodiments, the support member 102, the first elongate member 104, and the second elongate member 106 are made of a flexible material. In other embodiments, the support member 102, the first elongate member 104, and the second elongate member 106 are made of an elastic material. In some embodiments, the support member 102, the first elongate member 104, and the second elongate member 106 are formed of the same material. In certain other embodiments, the support member 102, the first elongate member 104, and the second elongate member 106 are formed of different materials. For example, the support member 102 can be formed from a first biocompatible material, and the first elongate member 104 and the second elongate member 106 can be formed from a second biocompatible material different than the first biocompatible material.


In some embodiments, the support member 102, the first elongate member 104, and the second elongate member 106 are formed of a material that allows tissue in-growth after implantation. In some embodiments, the elastic and flexible synthetic material employed in the support member 102, the first elongate member 104, and the second elongate member 106 may allow stretching of the medical device 100 without abdominal straining. Additionally, the medical device 100 may be coated, impregnated, or formed with one or more drugs to be eluted to an adjacent tissue, in accordance with several other embodiments.


The support member 102, the first elongate member 104, and the second elongate member 106 can have a variety of sizes (length, width, and thickness) depending on the intended use of a particular medical device such as the medical device 100 and the intended site of implantation. For example, the size of the support member 102 can depend on the size of the vaginal wall. Similarly, the size of the first elongate member 104 and the second elongate member 106 can have a length such that the support member 102 can be placed through and secured to the surrounding bodily tissues properly.


The coupling member 108 includes the first portion 118 and the second portion 120. The first portion 118 of the coupling member 108 is coupled to the distal end portion 112 of the first elongate member 104 and the second portion 120 of the coupling member 108 is coupled to the distal end portion 116 of the second elongate member 106 such that the first portion 118 of the coupling member 108 and the second portion 120 of the coupling member 108 are configured to be coupled together.


The first portion 118 of the coupling member 108 may include a male button. The second portion 120 of the coupling member 108 may include a female button. In some embodiments, the male and female buttons can be made of a polymeric material that may include a natural and/or a synthetic material. Exemplary polymeric materials are polypropylene, polyester, polyethylene, nylon, PVC, polystyrene, and the like. The male and female buttons are preferably made of a non-absorbable plastic material. In other embodiments the buttons may be made of biodegradable plastic material such as Polyglycolide (PGA), Polydioxanone (PDO) and the like.


The medical device 100 may further include a first suture and a second suture (not shown in FIG. 1). The first suture includes a proximal end portion and a distal end portion and the second suture also includes a proximal end portion and a distal end portion. The proximal end portion of the first suture is coupled to the first portion of the coupling member 108 and the distal end portion of the first suture is configured to be attached to a fourth bodily portion. The proximal end portion of the second suture is coupled to the second portion of the coupling member 108 and the distal end portion of the second suture is configured to be attached to a fifth bodily portion. In some embodiments, the fourth bodily portion and the fifth bodily portion is a sacrum of the patient. In some other embodiments the fourth bodily portion and the fifth bodily portion are other locations close to the sacrum. In some embodiments, the fourth bodily portion and the fifth bodily portion are same. In some other embodiments, the fourth bodily portion and the fifth bodily portion are different.


In some embodiments, the first suture and the second suture (together hereafter referred to as sutures) may be made of biological materials and/or synthetic materials. The sutures may be either absorbable (naturally biodegradable in the body) or non-absorbable. Exemplary absorbable sutures are polyglycolic acid, polylactic acid, polydioxanone, and the like. Exemplary non-absorbable sutures are nylon, polypropylene and the like. The biologic sutures can be made from biological materials, such as catgut suture, silk and the like. The sutures may be strong enough to hold the medical device securely and may also be flexible enough to be knotted.


In some embodiments, the first suture and the second suture are pulled toward sacrum or a portion of the sacrum with an appropriate tension thereby pulling the support member 102, the first elongate member 104, and the second elongate member 106 upward. This helps in lifting the prolapsed organs such as the anterior vaginal wall, posterior vaginal wall, cervix, and the uterus. An appropriate support is thus provided to the prolapsed organs by the medical device 100.



FIG. 2 is a perspective illustration of a medical device 200 configured to be delivered into a patient's body for the treatment of pelvic floor repair, in accordance with an embodiment of the present invention. The medical device 200 includes a support member 202, a first elongate member 204, a second elongate member 206, and a coupling member 208.


The support member 202 is configured to be placed within a patient's body such that the support member 202 is attached or stitched to a first bodily portion. In some embodiments, the first bodily portion is a portion of an anterior vaginal wall of the patient such that the support member 202 is attached or stitched to the portion of the anterior vaginal wall. In other embodiments, the first bodily portion is a portion of the posterior vaginal wall of the patient such that the support member 202 is attached or stitched to the portion of the posterior vaginal wall.


The support member 202 can be of a variety of different shapes, sizes, and configurations depending on the indented use of the medical device 200 and location of its placement within the body of the patient. In some embodiments, the support member 202 can be substantially rectangular, square, oval, or elliptical. The support member 202 can be shaped and sized in conformation to the portions of the vaginal walls of the patient where it is attached or stitched. In accordance with several embodiments, the support member 202 may be configured to conform to the shape of the body of the patient. For example, the support member 202 may be placed in a crescent shape, such as in the shape of a crescent moon, to help it conform to the anterior wall of the vagina.


The first elongate member 204 extends from the support member 202. The first elongate member 204 includes a proximal end portion 210 and a distal end portion 212 such that the proximal end portion 210 is attached to the support member 202 and the distal end portion 212 of the first elongate member 204 is configured to be attached around a second bodily portion. In some embodiments, the second bodily portion is a portion of a uterus of the patient such that the distal end portion 212 of the first elongate member 204 is wrapped around the portion of the uterus. In other embodiments, the second bodily portion is a portion of a cervix of the patient such that the distal end portion 212 of the first elongate member 204 is wrapped around the portion of the cervix.


The second elongate member 206 extends from the support member 202. The second elongate member 206 includes a proximal end portion 214 and a distal end portion 216 such that the proximal end portion 214 is attached to the support member 202 and the distal end portion 216 of the second elongate member 206 is configured to be attached around a third bodily portion. In some embodiments, the third bodily portion is a portion of a uterus of the patient such that the distal end portion 216 of the second elongate member 206 is wrapped around the portion of the uterus. In other embodiments, the third bodily portion is a portion of the cervix of the patient such that the distal end portion 216 of the second elongate member 206 is wrapped around the portion of the uterus. In some embodiments, the second bodily portion and the third bodily portion are same. In some other embodiments, the second bodily portion and the third bodily portion are different.


The first elongate member 204 and the second elongate member 206 can be of a variety of different shapes, sizes, and configurations depending on the indented use of the medical device 100 and location of its placement within the body of the patient. In some embodiments, the first elongate member 204 and the second elongate member 206 can be substantially planar, cylindrical, tubular, vasiform, cannular and the like. The first elongate member 204 and the second elongate member 206 can be shaped and sized to support the portion of the vaginal wall of the patient. In accordance with several embodiments, the first elongate member 204 and the second elongate member 206 may be configured to conform to the shape of the body of the patient. For example, the first and the second elongate members 204 and 206 may be placed in a cylindrical shape, such as in the shape of a hollow cylinder, to help it conform to and wrap around the cervix or the uterus of the patient.


In some embodiments, the first elongate member 204 and the second elongate member 206 are integral portions of the support member 202 such that the support member 202, the first elongate member 204 and the second elongate member 206 form a single integral structure. In other embodiments, the first elongate member 204 and the second elongate member 206 are removably or fixedly coupled to the support member 202. The first elongate member 204 and the second elongate member 206 may extend from any location of the support member 202 such that the medical device 200 comfortably supports and retains body portions of the patient. In some cases, the first elongated member 204 and the second elongated member 206 can be coupled to the support member 202 at two symmetric locations on either side of a central axis of the support member 202. In other cases, the first elongate member 204 and the second elongate member 206 can be coupled to the support member 202 at diametrically opposite locations.


In some embodiments, the support member 202, the first elongate member 204, and the second elongate member 206 are formed of a material that allows tissue in-growth after implantation. Various types of materials that can be employed to manufacture the support member 202, the first elongate member 204, and the second elongate member 206 have been described in conjunction with FIG. 1.


The support member 202, the first elongate member 204, and the second elongate member 206 can have a variety of sizes (length, width, and thickness) depending on the intended use of a particular medical device such as the medical device 200 and the intended site of implantation. For example, the size of the support member 202 can depend on the size of the vaginal wall. Similarly, the size of the first elongate member 204 and second elongate member 206 can have a length such that the support member 202 can be placed through and secured to the surrounding bodily tissues properly.


The coupling member 208 includes a first portion 218 and a second portion 220. The first portion 218 of the coupling member 208 is coupled to the distal end portion 212 of the first elongate member 204 and the second portion 220 of the coupling member 208 is coupled to the distal end portion 216 of the second elongate member 206, wherein the first portion 218 of the coupling member 208 and the second portion 220 of the coupling member 208 are configured to be coupled together. The first portion 218 of the coupling member 208 includes a male button 222. The second portion 220 of the coupling member 208 includes a female button 224. The male button 222 of the coupling member 208 is configured to be plugged in to the female button 224 of the coupling member 208 thereby coupling the first elongate member 204 and the second elongate member 206 together. The male and female buttons 222 and 224 of the coupling member 208 are further described in conjunction with FIG. 3.


The medical device 200 also includes a first suture 226 and a second suture 228. The first suture 226 includes a proximal end portion 230 and a distal end portion 232 and the second suture 228 also includes a proximal end portion 234 and a distal end portion 236. The proximal end portion 230 of the first suture 226 is coupled to the first portion 218 of the coupling member 208 and the distal end portion 232 of the first suture 226 is configured to be attached to a fourth bodily portion. The proximal end portion 234 of the second suture 228 is coupled to the second portion 220 of the coupling member 208 and the distal end portion 236 of the second suture 228 is configured to be attached to a fifth bodily portion. In some embodiments, the fourth bodily portion and the fifth bodily portion is a sacrum of the patient. In some other embodiments, the fourth bodily portion and the fifth bodily portion can be any other location close to the sacrum. In some embodiments, the second bodily portion and the third bodily portion are same. In some other embodiments, the second bodily portion and the third bodily portion are different. The first suture 226 and the second suture 228 have also been discussed in conjunction with FIG. 1 in detail.



FIG. 3A illustrates an enlarged view of a coupling member 302 in a decoupled state in accordance with an embodiment of the present invention. The coupling member 302 includes a first portion 304 and a second portion 306. The first portion 304 of the coupling member 302 includes a male button 308. The second portion 306 of the coupling member includes a female button 310. The male button 308 includes a head portion 312 and a leg portion 314. The head portion 312 can be a disc or harrow shaped structure, and the like. The leg portion 314 is a cylindrical extension from the head portion 312.


The female button 310 includes a head portion 316 such that the head portion 316 is a disc or harrow shaped structure, and the like. The head portion 316 of the female button 310 is hollow formed by inner peripheral surfaces of the female button 310. The cylindrical leg portion 314 of the male button 308 is capable of passing through the hollow portion formed by the inner peripheral surfaces of the female button 310. The male button 308 of the coupling member 302 and the female button 310 of the coupling member 302 are configured to be removably coupled together as illustrated in FIG. 4B. The male button 308 can be further pressed, thereby allowing the male button 308 to be fitted to the female button 310. In some embodiments, the removable coupling between the male button 308 of the coupling member 302 and the female button 310 of the coupling member 302 can be frictional fit or press fit which is achieved by friction after the parts are pushed together. The frictional or press fit can be achieved by pressing the two buttons 308 and 310 together against one another. In other embodiments, the removable coupling between the male button 308 of the coupling member 302 and the female button 310 of the coupling member 302 can be achieved through other mechanisms and fasteners such as springs, pins, and the like. In some embodiments, the coupling member 302 is a snap type coupling member.


The coupling member 202, first portion 204, and the second portion 206 as described above for coupling purposes is merely exemplary and it must be appreciated that various other types of coupling members as used in the conventional art can also be employed for the purposes of the present invention.



FIG. 4A-4C illustrate perspective views of placement of the medical device 200 within a patient's body, in accordance with an embodiment of the present invention. FIG. 4A illustrates a view of placement from a top side of a vaginal opening. FIG. 4B illustrates a view of placement from a bottom side of the vaginal opening. FIG. 4C illustrates a view of placement with the coupling member 208 in a coupled state. The body portions of the patient such as a vagina (vaginal opening) 402, an anterior vaginal wall 404, a posterior vaginal wall 406, a sacrum 408, a cervix 410, and a uterus 412 are illustrated in FIGS. 4A-4C. The medical device 200 is hereafter used to describe the placement within the patient's body. However, other medical devices such as the medical device 100 may also be employed, in accordance with other embodiments of the present invention.


As illustrated, the support member 202 is attached or stitched to a portion of the anterior vaginal wall 404 of the patient. In other embodiments, the support member 202 may be attached or stitched to a portion of the posterior vaginal wall 406. In accordance with the illustrated embodiment, the support member 202 can be shaped and sized in conformation to the portion of the anterior vaginal wall 404 of the patient where it is attached or stitched. For example, the support member 202 may be placed in a crescent shape, such as in the shape of a crescent moon, to help it conform to the anterior vaginal wall 404. The first elongate member 204 extends from the support member 202. The proximal end portion 210 of the first elongate member 204 is attached to the support member 202 and the distal end portion 212 of the first elongate member 204 is attached around a portion of the uterus 412. The second elongate member 206 also extends from the support member 202. The proximal end portion 214 of the second elongate member 206 is attached to the support member 202 and the distal end portion 216 of the second elongate member 206 is attached around a portion of the uterus 412. Further, the proximal end portion 230 of the first suture 226 is coupled to the first portion 218 of the coupling member 208 and the distal end portion 232 of the first suture 226 is attached to the sacrum or close to the sacrum 408. The proximal end portion 234 of the second suture 228 is coupled to the second portion 220 of the coupling member 208 and the distal end portion 236 of the second suture 228 is attached to the sacrum or close to the sacrum 408.



FIG. 5 is a flowchart illustrating a method 500 of placement of a medical device such as the medical device 100 or the medical device 200, in accordance with an embodiment of the present invention.


Referring now to FIG. 5 in conjunction with FIGS. 4A-4C, the method 500 of placement of the medical device 200 is described in accordance with an embodiment of the present invention. The medical device 200 is hereafter used to describe the placement in an exemplary embodiment. However, it must be appreciated that the medical device 100 may also be placed in the similar manner.


The method 500 includes delivering the medical device 200 inside the patient's body at step 502. The medical device 200 includes the support member 202, the first elongate member 204, and the second elongate member 206 extending from the support member 202. The medical device 200 further includes the coupling member 208 having the first portion 218 and the second portion 220. The medical device 200 has been described above in conjunction with FIG. 2. In some embodiments, an abdominal access may be crated to deliver the medical device 200 inside the patient's body. In other embodiments, a transvaginal access may be created for the delivery of the medical device 200. In accordance with various embodiments, an operator or a surgeon may make abdominal or vaginal incisions laproscopically, laprotomically, or in any other manner.


The method further includes coupling the first portion 218 of the coupling member 208 with the second portion 220 of the coupling member 208 at step 504. Coupling of the first portion 218 and the second portion 220 can be done through male and female buttons 222 and 224 as illustrated in FIGS. 2-3B. The male button 222 is configured to fit inside the female button 224. Various other coupling arrangements can also be used to couple the first portion 218 with the second portion 220.


After the medical device 200 is delivered and the first portion 218 is coupled with the second portion 220, the operator may wrap the first elongate member 204 and the second elongate member 206 around the cervix 410 or the uterus 412 or a portion of the cervix 410 or the uterus 412 of the patient. Thus, the wrapped elongate members 204 and 206 together with the support member 202 provide a desired support to the anterior and/or posterior vaginal walls 404 and 406 and the cervix or the uterus 410 and 412 of the patient. Similarly, any other prolapsed organ can be supported and lifted with the use of the medical device 200.


The method further includes fixing the first suture 226 and the second suture 228 to the sacrum 408 of the patient. As discussed in conjunction with FIG. 2 in detail, the first suture 226 is attached to the first portion 218 of the coupling member 208 through its proximal end and the second suture 228 is attached to the second portion 220 of the coupling member 208 through its proximal end. In order to ensure proper placement of the medical device 200 and proper fixation of the first suture 226 and the second suture 228, the medical device 200 may be pulled sufficiently to a defined anatomical location with the use of the first suture 226 and the second suture 228. The fixation of the sutures 226 and 228 to the sacrum 208 provides a desired tension to the support member 202.


In some embodiments, the sutures 226 and 228 are pulled toward sacrum 208 with an appropriate tension thereby pulling the support member 202, the first elongate member 204, and the second elongate member 206 upward. This helps in lifting the prolapsed organs such as the anterior vaginal wall 404, posterior vaginal wall 406, cervix 410, and the uterus 412. An appropriate support is thus provided to the prolapsed organs by the medical device 200.


It must be appreciated that the coupling of the first and second portion 218 and 220 of the coupling member 208 holds the first elongate member 204 and the second elongate member 206 together at the uterus or the cervix 412/410 but may not appropriately tension them. In some embodiments, it is through the first suture 226 and the second suture 228 that the tension capable of treating pelvic disorders is provided. In some embodiments, since the sutures 226 and 228 are very thin as compared to the width of the elongate members 204 and 206, therefore they can be passed through anatomical locations from the vaginal walls 404 and 406 to the sacrum 408 easily. Therefore, removal of the uterus 412 is avoided through the disclosed surgical procedure.


In some embodiments, a medical device configured to be delivered and placed within a patient's body includes a support member, a first elongate member, a second elongate member and a coupling member. The support member is configured to be attached to a portion of a vaginal wall. The first elongate member extends from the support member, the first elongate member having a proximal end portion and a distal end portion such that the proximal end portion is attached to the support member and the distal end portion of the first elongate member being configured to be attached around a portion of a uterus. The second elongate member extending from the support member, the second elongate member having a proximal end portion and a distal end portion such that the proximal end portion is attached to the support member and the distal end portion of the second elongate member being configured to be attached around a portion of the uterus. The coupling member having a first portion and a second portion, the first portion of the coupling member coupled to the distal end portion of the first elongate member and the second portion of the coupling member coupled to the distal end portion of the second elongate member, wherein the first portion of the coupling member and the second portion of the coupling member are configured to be coupled together.


In some embodiments, the medical device is a bodily implant configured to treat uterine prolapse. In some embodiments, the support member includes a mesh configured to be stitched to the portion of the vaginal wall. In some embodiments, the vaginal wall is an anterior vaginal wall of the patient such that the support member is configured to be stitched to the anterior vaginal wall. In some embodiments, the coupling member is made of a plastic. In some embodiments, the plastic is polypropylene. In some embodiments, the coupling member is made of a biodegradable material. In some embodiments, the first portion of the coupling member includes a male button. In some embodiments, the second portion of the coupling member includes a female button. In some embodiments, the coupling member is made of a non-absorbable plastic. In some embodiments, the coupling member is made of a biodegradable material.


In some embodiments, the device includes a first suture having a proximal end portion and a distal end portion, wherein the proximal end portion of the first suture is coupled to the first portion of the coupling member and the distal end portion of the first suture is configured to be attached to a portion of a sacrum of the patient.


In some embodiments, the device includes a second suture having a proximal end portion and a distal end portion, wherein the proximal end portion of the second suture is coupled to the second portion of the coupling member and the distal end portion of the second suture is configured to be attached to a portion of the sacrum of the patient.


In some embodiments, a method of placing a medical device in a patient's body, includes delivering the medical device inside the patient's body, the medical device having a support member configured to be attached to a portion of a vaginal wall, a first elongate member and a second elongate member extending from the support member and configured to be attached around a portion of a uterus, a coupling member having a first portion and a second portion, the first portion of the coupling member coupled to the first elongate member and the second portion of the coupling member coupled to the second elongate member; coupling the first portion of the coupling member with the second portion of the coupling member; and fixing a first suture and a second suture to a sacrum of the patient, the first suture attached to the first portion of the coupling member through its proximal end and the second suture attached to the second portion of the coupling member through its proximal end.


In some embodiments, the method includes creating an access to a vagina for delivery of the medical device. In some embodiments, the access is created transvaginally.


In some embodiments, the method includes stitching the support member to the portion of the vaginal wall. In some embodiments, the vaginal wall is an anterior vaginal wall.


In some embodiments, the method includes pulling the medical device to a defined anatomical location with the use of the first suture and the second suture. In some embodiments, the medical device is a bodily implant configured to treat uterine prolapse.


While the invention has been disclosed in connection with the preferred embodiments shown and described in detail, various modifications and improvements thereon will become readily apparent to those skilled in the art. Accordingly, the spirit and scope of the present invention is not to be limited by the foregoing examples, but it is to be understood in the broadest sense allowable by law.

Claims
  • 1. A medical device configured to be delivered and placed within a patient's body, the medical device comprising: a support member configured to be attached to a portion of a vaginal wall;a first elongate member extending from the support member, the first elongate member having a proximal end portion and a distal end portion such that the proximal end portion is attached to the support member and the distal end portion of the first elongate member being configured to be attached around a portion of a uterus;a second elongate member extending from the support member, the second elongate member having a proximal end portion and a distal end portion such that the proximal end portion is attached to the support member and the distal end portion of the second elongate member being configured to be attached around a portion of the uterus;a coupling member having a first portion and a second portion, the first portion of the coupling member coupled to the distal end portion of the first elongate member and the second portion of the coupling member coupled to the distal end portion of the second elongate member,wherein the first portion of the coupling member and the second portion of the coupling member are configured to be directly coupled together such that the distal end portion of the first elongate member is coupled to the distal end portion of the second elongate member;a first suture coupled to the first portion of the coupling member on the first elongate member; anda second suture coupled to the second portion of the coupling member on the second elongate member,wherein, when the first portion of the coupling member is directly coupled to the second portion of the coupling member, the first suture and the second suture are each configured to extend from the coupling member to different portions of bodily tissue within the patient's body.
  • 2. The medical device of claim 1, wherein the medical device is a bodily implant configured to treat uterine prolapse.
  • 3. The medical device of claim 1, wherein the support member includes a mesh configured to be stitched to the portion of the vaginal wall.
  • 4. The medical device of claim 1, wherein the vaginal wall is an anterior vaginal wall of the patient such that the support member is configured to be stitched to the anterior vaginal wall.
  • 5. The medical device of claim 1, wherein the coupling member is made of a plastic.
  • 6. The medical device of claim 5, wherein the plastic is polypropylene.
  • 7. The medical device of claim 1, wherein the coupling member is made of a biodegradable material.
  • 8. The medical device of claim 1, wherein the first portion of the coupling member is a male button, and the second portion of the coupling member is a female button.
  • 9. The medical device of claim 1, wherein the second portion of the coupling member defines an opening, and the first portion of the coupling member is configured to be inserted into the opening of the second portion of the coupling member.
  • 10. The medical device of claim 1, wherein the first and second elongate members are coupled to the support member at two symmetric locations with respect to a central axis of the support member.
  • 11. The medical device of claim 1, wherein the first portion of the coupling member includes a head portion having a disc shape, the first portion of the coupling member including a leg portion, the leg portion being a cylindrical extension from the head portion, the second portion of the coupling member having a head portion defining a cavity formed by inner peripheral surfaces of the second portion of the coupling member.
  • 12. The medical device of claim 1, wherein the first suture includes a proximal end portion and a distal end portion, wherein the proximal end portion of the first suture is coupled to the first portion of the coupling member and the distal end portion of the first suture is configured to be attached to a portion of a sacrum of the patient.
  • 13. The medical device of claim 12, wherein the second suture includes a proximal end portion and a distal end portion, wherein the proximal end portion of the second suture is coupled to the second portion of the coupling member and the distal end portion of the second suture is configured to be attached to another portion of the sacrum of the patient.
  • 14. A method of placing a medical device in a patient's body, the method comprising: delivering the medical device inside the patient's body, the medical device having a support member configured to be attached to a portion of a vaginal wall, a first elongate member and a second elongate member extending from the support member and configured to be attached around a portion of a uterus, a coupling member having a first portion and a second portion, the first portion of the coupling member coupled to the first elongate member and the second portion of the coupling member coupled to the second elongate member, the medical device having a first suture coupled to the first portion of the coupling member, and a second suture coupled to the second portion of the coupling member;directly coupling the first portion of the coupling member with the second portion of the coupling member such that a distal end portion of the first elongate member is coupled to a distal end portion of the second elongate member, the first and second sutures extending from the coupling member from a portion of a uterus of the patient; andextending the first and second sutures from the portion of the uterus to different portions of a sacrum of the patient including, extending the first suture to a first portion of the sacrum of the patient; andextending the second suture to a second portion of the sacrum of the patient.
  • 15. The method of claim 14 further comprising creating an access to a vagina for delivery of the medical device.
  • 16. The method of claim 15, wherein the access is created transvaginally.
  • 17. The method of claim 14, further comprising stitching the support member to the portion of the vaginal wall.
  • 18. The method of claim 14, wherein the vaginal wall is an anterior vaginal wall.
  • 19. The method of claim 14 further comprising pulling the medical device to a defined anatomical location with use of the first suture and the second suture.
  • 20. The method of claim 14, wherein the medical device is a bodily implant configured to treat uterine prolapse.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a Nonprovisional of, and claims priority to, U.S. Patent Application No. 61/532,809, filed Sep. 9, 2011, entitled “A MEDICAL DEVICE AND METHODS OF DELIVERING THE MEDICAL DEVICE”, which is incorporated by reference herein in its entirety.

US Referenced Citations (272)
Number Name Date Kind
669034 Manly Feb 1901 A
2687131 Raiche Aug 1954 A
3123077 Alcamo Mar 1964 A
4083369 Sinnreich Apr 1978 A
4324331 Ignasiak Apr 1982 A
4792336 Hlavacek et al. Dec 1988 A
4919667 Richmond Apr 1990 A
4998912 Scarbrough et al. Mar 1991 A
5013292 Lemay May 1991 A
5082112 Dunklee Jan 1992 A
5112344 Petros May 1992 A
5149329 Richardson Sep 1992 A
5217466 Hasson Jun 1993 A
5217486 Rice et al. Jun 1993 A
5217494 Coggins et al. Jun 1993 A
5263969 Phillips Nov 1993 A
5356432 Rutkow et al. Oct 1994 A
5362294 Seitzinger Nov 1994 A
5364408 Gordon Nov 1994 A
5383905 Golds et al. Jan 1995 A
5405359 Pierce Apr 1995 A
5425747 Brotz Jun 1995 A
5451235 Lock et al. Sep 1995 A
5458609 Gordon et al. Oct 1995 A
5458636 Brancato Oct 1995 A
5464409 Mohajer Nov 1995 A
5485917 Early Jan 1996 A
5527341 Gogolewski et al. Jun 1996 A
5534008 Acksel Jul 1996 A
5540704 Gordon et al. Jul 1996 A
5562689 Green et al. Oct 1996 A
5569283 Green et al. Oct 1996 A
5575800 Gordon Nov 1996 A
5578044 Gordon et al. Nov 1996 A
5584859 Brotz Dec 1996 A
5611515 Benderev et al. Mar 1997 A
5643311 Smith et al. Jul 1997 A
5662664 Gordon Sep 1997 A
5683402 Cosgrove et al. Nov 1997 A
5700272 Gordon et al. Dec 1997 A
5702397 Goble et al. Dec 1997 A
5713910 Gordon et al. Feb 1998 A
5720761 Kaali Feb 1998 A
5741277 Gordon et al. Apr 1998 A
5741279 Gordon et al. Apr 1998 A
5741299 Rudt Apr 1998 A
5840011 Landgrebe et al. Nov 1998 A
5871488 Tovey et al. Feb 1999 A
5899909 Claren et al. May 1999 A
5922826 Kuze et al. Jul 1999 A
5931855 Buncke Aug 1999 A
5948001 Larsen Sep 1999 A
5976127 Lax Nov 1999 A
5988549 Hitomi et al. Nov 1999 A
6010447 Kardjian Jan 2000 A
6012580 Peters et al. Jan 2000 A
6039686 Kovac Mar 2000 A
6042534 Gellman et al. Mar 2000 A
6042536 Tihon et al. Mar 2000 A
6042592 Schmitt Mar 2000 A
6044847 Carter et al. Apr 2000 A
6048351 Gordon et al. Apr 2000 A
6096051 Kortenbach et al. Aug 2000 A
6102921 Zhu et al. Aug 2000 A
6195646 Grosh et al. Feb 2001 B1
6197036 Tripp et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6221005 Bruckner et al. Apr 2001 B1
6224616 Kugel May 2001 B1
6267772 Mulhauser et al. Jul 2001 B1
6273852 Lehe et al. Aug 2001 B1
6306079 Trabucco Oct 2001 B1
6322492 Kovac Nov 2001 B1
6328686 Kovac Dec 2001 B1
6346111 Gordon et al. Feb 2002 B1
6375662 Schmitt Apr 2002 B1
6382214 Raz et al. May 2002 B1
6406423 Scetbon Jun 2002 B1
6454778 Kortenbach Sep 2002 B2
6478727 Scetbon Nov 2002 B2
6491703 Ulmsten Dec 2002 B1
6502578 Raz et al. Jan 2003 B2
6506190 Walshe Jan 2003 B1
6530943 Hoepffner et al. Mar 2003 B1
6544273 Harari et al. Apr 2003 B1
6547800 Foerster et al. Apr 2003 B2
6551329 Kortenbach et al. Apr 2003 B1
6565580 Beretta May 2003 B1
6575998 Beyar Jun 2003 B2
6582443 Cabak et al. Jun 2003 B2
6592515 Thierfelder et al. Jul 2003 B2
6592610 Beyar et al. Jul 2003 B2
6595911 LoVuolo Jul 2003 B2
6596001 Stormby et al. Jul 2003 B2
6599235 Kovac Jul 2003 B2
6599310 Leung et al. Jul 2003 B2
6612977 Staskin et al. Sep 2003 B2
6638209 Landgrebe Oct 2003 B2
6638210 Berger Oct 2003 B2
6638211 Suslian et al. Oct 2003 B2
6638284 Rousseau et al. Oct 2003 B1
6641524 Kovac et al. Nov 2003 B2
6641525 Rocheleau et al. Nov 2003 B2
6648899 Kalinski et al. Nov 2003 B2
6648921 Anderson et al. Nov 2003 B2
6652450 Neisz et al. Nov 2003 B2
6666817 Li Dec 2003 B2
6669706 Schmitt et al. Dec 2003 B2
6669735 Pelissier Dec 2003 B1
6673010 Skiba et al. Jan 2004 B2
6691711 Raz et al. Feb 2004 B2
6695855 Gaston Feb 2004 B1
6702827 Lund et al. Mar 2004 B1
6730110 Harari et al. May 2004 B1
6746455 Beyar et al. Jun 2004 B2
6752814 Gellman et al. Jun 2004 B2
6755781 Gellman Jun 2004 B2
6808487 Migliari Oct 2004 B2
6830052 Carter et al. Dec 2004 B2
6848152 Genova Feb 2005 B2
6881184 Zappala Apr 2005 B2
6890338 Davis et al. May 2005 B1
6908425 Luscombe Jun 2005 B2
6911003 Anderson et al. Jun 2005 B2
6911034 Nobles et al. Jun 2005 B2
6932759 Kammerer et al. Aug 2005 B2
6936052 Gellman et al. Aug 2005 B2
6936054 Chu Aug 2005 B2
6936952 Takamine Aug 2005 B2
6946003 Wolowacz et al. Sep 2005 B1
6953428 Gellman et al. Oct 2005 B2
6960160 Browning Nov 2005 B2
6971986 Staskin et al. Dec 2005 B2
6986780 Rudnick et al. Jan 2006 B2
6991597 Gellman et al. Jan 2006 B2
7011688 Gryska et al. Mar 2006 B2
7025772 Gellman et al. Apr 2006 B2
7048682 Neisz et al. May 2006 B2
7056333 Walshe Jun 2006 B2
7070556 Anderson et al. Jul 2006 B2
7070558 Gellman et al. Jul 2006 B2
7083568 Neisz et al. Aug 2006 B2
7083637 Tannhauser Aug 2006 B1
7090686 Nobles et al. Aug 2006 B2
7094199 Petros et al. Aug 2006 B2
7112171 Rocheleau et al. Sep 2006 B2
7112210 Ulmsten et al. Sep 2006 B2
7122039 Chu Oct 2006 B2
7131943 Kammerer Nov 2006 B2
7131944 Jacquetin Nov 2006 B2
7198597 Siegel et al. Apr 2007 B2
7204801 Grocela Apr 2007 B2
7204802 De Leval Apr 2007 B2
7223229 Inman et al. May 2007 B2
7226407 Kammerer et al. Jun 2007 B2
7226408 Harai et al. Jun 2007 B2
7229453 Anderson et al. Jun 2007 B2
7235043 Gellman et al. Jun 2007 B2
7244260 Koseki Jul 2007 B2
7244759 Muller et al. Jul 2007 B2
7267645 Anderson et al. Sep 2007 B2
7291104 Neisz et al. Nov 2007 B2
7351197 Montpetit et al. Apr 2008 B2
7361138 Wagner et al. Apr 2008 B2
7364541 Chu et al. Apr 2008 B2
7402133 Chu et al. Jul 2008 B2
7413540 Gellman et al. Aug 2008 B2
7527588 Zaddem May 2009 B2
7878970 Goldberg Feb 2011 B2
20010023356 Raz et al. Sep 2001 A1
20010049467 Lehe et al. Dec 2001 A1
20020010457 Duchon et al. Jan 2002 A1
20020028980 Thierfelder et al. Mar 2002 A1
20020099259 Anderson et al. Jul 2002 A1
20020128670 Ulmsten et al. Sep 2002 A1
20020133236 Rousseau Sep 2002 A1
20020143234 LoVuolo Oct 2002 A1
20020147382 Neisz et al. Oct 2002 A1
20020151909 Gellman et al. Oct 2002 A1
20020156489 Gellman et al. Oct 2002 A1
20030009181 Gellman et al. Jan 2003 A1
20030023138 Luscombe Jan 2003 A1
20030023250 Watschke et al. Jan 2003 A1
20030055313 Anderson et al. Mar 2003 A1
20030078604 Walshe Apr 2003 A1
20030125715 Kuehn et al. Jul 2003 A1
20030149334 Ulmsten et al. Aug 2003 A1
20030176762 Kammerer Sep 2003 A1
20030191360 Browning Oct 2003 A1
20030208208 Chu Nov 2003 A1
20030220538 Jacquetin Nov 2003 A1
20030225424 Benderev Dec 2003 A1
20030233107 Gellman et al. Dec 2003 A1
20030233108 Gellman et al. Dec 2003 A1
20040006353 Bosley et al. Jan 2004 A1
20040015048 Neisz et al. Jan 2004 A1
20040015177 Chu Jan 2004 A1
20040034372 Chu Feb 2004 A1
20040039246 Gellman et al. Feb 2004 A1
20040039453 Anderson et al. Feb 2004 A1
20040059293 Chu et al. Mar 2004 A1
20040068159 Neisz et al. Apr 2004 A1
20040073234 Chu et al. Apr 2004 A1
20040087970 Chu et al. May 2004 A1
20040106847 Benderev Jun 2004 A1
20040116944 Chu et al. Jun 2004 A1
20040133217 Watschke Jul 2004 A1
20040138747 Kaladelfos Jul 2004 A1
20040181243 Chu et al. Sep 2004 A1
20040186515 Rosenblatt Sep 2004 A1
20040225181 Chu et al. Nov 2004 A1
20040230206 Gellman et al. Nov 2004 A1
20040231678 Fierro Nov 2004 A1
20040236356 Rioux et al. Nov 2004 A1
20040249397 Delorme et al. Dec 2004 A1
20040249473 Delorme et al. Dec 2004 A1
20050004427 Cervigni Jan 2005 A1
20050004576 Benderev Jan 2005 A1
20050038451 Rao et al. Feb 2005 A1
20050038452 Chu Feb 2005 A1
20050075660 Chu et al. Apr 2005 A1
20050080317 Merade Apr 2005 A1
20050090706 Gellman Apr 2005 A1
20050096499 Li et al. May 2005 A1
20050101834 Merade May 2005 A1
20050107805 Bouffier et al. May 2005 A1
20050131391 Chu et al. Jun 2005 A1
20050131392 Chu et al. Jun 2005 A1
20050131393 Chu et al. Jun 2005 A1
20050177022 Chu et al. Aug 2005 A1
20050192600 Nicolo et al. Sep 2005 A1
20050222589 Chu Oct 2005 A1
20050222591 Gingras et al. Oct 2005 A1
20050234291 Gingras Oct 2005 A1
20050245787 Cox et al. Nov 2005 A1
20050250977 Montpetit et al. Nov 2005 A1
20050250978 Kammerer Nov 2005 A1
20050256366 Chu Nov 2005 A1
20050256530 Petros Nov 2005 A1
20050261545 Gellman et al. Nov 2005 A1
20050261547 Bouffier Nov 2005 A1
20050277807 MacLean et al. Dec 2005 A1
20050278037 Delorme et al. Dec 2005 A1
20060015001 Staskin et al. Jan 2006 A1
20060025649 Smith et al. Feb 2006 A1
20060025783 Smith et al. Feb 2006 A1
20060041185 Browning Feb 2006 A1
20060041263 Chu et al. Feb 2006 A1
20060052801 Dreyfuss et al. Mar 2006 A1
20060058574 Priewe et al. Mar 2006 A1
20060058575 Zaddem et al. Mar 2006 A1
20060069301 Neisz et al. Mar 2006 A1
20060089524 Chu Apr 2006 A1
20060089525 Mamo et al. Apr 2006 A1
20060122457 Kovac et al. Jun 2006 A1
20060173237 Jacquetin Aug 2006 A1
20060205995 Browning Sep 2006 A1
20060211911 Jao et al. Sep 2006 A1
20060229596 Weiser et al. Oct 2006 A1
20060264698 Kondonis et al. Nov 2006 A1
20070161849 Goldberg et al. Jul 2007 A1
20070173864 Chu Jul 2007 A1
20070270890 Miller Nov 2007 A1
20070276358 Barzell et al. Nov 2007 A1
20080234543 Goldwasser Sep 2008 A1
20090171140 Chu Jul 2009 A1
20100130814 Dubernard May 2010 A1
20100152530 Timmer et al. Jun 2010 A1
20110098527 Goldberg Apr 2011 A1
20110112357 Chapman et al. May 2011 A1
20120059217 Goldberg Mar 2012 A1
20120136324 Hanuka et al. May 2012 A1
Foreign Referenced Citations (59)
Number Date Country
10056169 Jun 2002 DE
0088714 Sep 1983 EP
0141589 May 1985 EP
0299158 Jan 1989 EP
0362146 Apr 1990 EP
0412664 Feb 1991 EP
0567130 Oct 1993 EP
0774240 May 1997 EP
1201189 May 2002 EP
1508305 Feb 2005 EP
1520554 Apr 2005 EP
1609439 Dec 2005 EP
2785521 May 2000 FR
2852817 Oct 2004 FR
2852818 Oct 2004 FR
2871365 Dec 2005 FR
670349 Apr 1952 GB
06114067 Apr 1994 JP
08117239 May 1996 JP
PA04008407 Dec 2005 MX
9609796 Apr 1996 WO
9639948 Dec 1996 WO
9835616 Aug 1998 WO
9835632 Aug 1998 WO
9843545 Oct 1998 WO
9937216 Jul 1999 WO
0009039 Feb 2000 WO
0074613 Dec 2000 WO
0106951 Feb 2001 WO
0152135 Jul 2001 WO
0231681 Apr 2002 WO
0232284 Apr 2002 WO
0238079 May 2002 WO
02058563 Aug 2002 WO
02062237 Aug 2002 WO
02078571 Oct 2002 WO
03068107 Aug 2003 WO
03073960 Sep 2003 WO
03092546 Nov 2003 WO
03096928 Nov 2003 WO
03096929 Nov 2003 WO
2004012626 Feb 2004 WO
2004016196 Feb 2004 WO
2004045457 Oct 2004 WO
2004091442 Oct 2004 WO
2004091443 Oct 2004 WO
2005051204 Jun 2005 WO
2005122721 Dec 2005 WO
2005122954 Dec 2005 WO
2006046950 May 2006 WO
2007014240 Feb 2007 WO
2007016698 Feb 2007 WO
2007019374 Feb 2007 WO
2007038589 Apr 2007 WO
2007087132 Aug 2007 WO
2009038781 Mar 2009 WO
2009102945 Aug 2009 WO
2012030834 Mar 2012 WO
2012030834 Mar 2012 WO
Non-Patent Literature Citations (7)
Entry
Leron, E. et al., “Sacrohysteropexy with synthetic mesh for the management of uterovaginal prolapse”, British Journal of Obstetrics and Gynaecology, 108.3, 2001, pp. 629-633.
“Capio® CL Transvaginal Suture Capturing Device”, Transvaginal Suture Fixation to Cooper's Ligament for Sling Procedures, Boston Scientific, 2000, 4 pages.
“Capio® Open Access and Standard Suture Capturing Devices”, Reach, Throw and Capture: One Step. One Device., Boston Scientific, printed on Apr. 7, 2006, 2 pages.
“Capio® RP Suture Device”, Boston Scientific, printed on Apr. 7, 2006, 1 page.
Hardiman, et al, “Sacrospinous Vault Suspension and Abdonimal Colposacropexy: Success Rates and Complications”, Section of Urogynecology, Department of Obstetrics and Gynecology, University of Toronto, Mount Sinai Hospital, Sep. 18, 1995, 5 pages.
Pohl, et al, “Bilateral Transvaginal Sacrospinous Colpopexy: Preliminary Experience”, 23rd Annual Meeting of the Society of Gynecologic Surgeons, Feb. 24-26, 1997, 7 pages.
Shah, et al, “Short-Term Outcome Analysis of Total Pelvic Reconstruction With Mesh: The Vaginal Approach”, The Journal of Urology, vol. 171, Jan. 2004, pp. 261-263.
Related Publications (1)
Number Date Country
20130066145 A1 Mar 2013 US
Provisional Applications (1)
Number Date Country
61532809 Sep 2011 US